These markers include the established mitotic indices Ki-67 and MCM2, as well as a set of regulatory proteins which have previously shown prognostic potential in assessing the outcome of breast cancer, i.e. geminin, separase, PLK1, aurora A, securin, cyclinB1 and CDK1-3. This evidence concerns the gene GMNN and breast carcinoma.